嘉瑞国际(00822)中期纯利预降15%至30%
格隆汇8月12日丨嘉瑞国际(00822)公布,集团预期截至2019年6月30日止六个月的公司权益持有人应占综合溢利与去年同期比较录得约15至30%的跌幅。
此预期下跌主要是由于下列原因:一般营商环境的不确定性引致收入减少,尤其是中国和美国不断升级的贸易争端导致集团的订单减少;及虽然一般及行政开支对比去年同期录得跌幅,但该跌幅对比收入的减少幅度为小,主要是由于(其中包括)集团生产设施持续整合所产生的支出所致。
为应对目前营商环境的困难和挑战,集团将继续实施严紧之成本控制措施、增加生产自动化及研发新产品和技术,从而提高营运效率和达致产品多样化,及密切监察市场形势,在有需要时调整策略和营运。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.